Education
About Us
Working with TipRanks
Follow Us
Evolus Inc (EOLS)
NASDAQ:EOLS
Earnings Data
Report Date
Jul 30, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.09Last Year’s EPS
-0.04Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 07, 2025
|% Change Since: -14.20%
|Next Earnings Date:Jul 30, 2025
Earnings Call Sentiment|Positive
Evolus reported strong revenue growth and a successful product launch, with significant customer engagement and financial repositioning. However, challenges include reduced market growth expectations, tariff impacts, and increased operating expenses. Despite these challenges, the company's strategic execution and market share gains indicate a positive outlook.Company Guidance
In the first quarter of 2025, Evolus reported $68.5 million in revenue, marking a 15.5% increase from the previous year, as they gained market share despite a slower overall market growth. The company launched Evolysse Form and Evolysse Smooth in the U.S., transitioning to a multi-product company and driving engagement with their "Drop the F Word" campaign, which encourages a shift in terminology from "filler" to "hyaluronic acid." Evolus reaffirmed their 2025 revenue guidance of $345 million to $355 million, predicting over 30% annual growth. They noted a strong customer base with 675 new accounts added, and over 220,000 loyalty program redemptions, 65% from existing consumers. The company's non-GAAP operating expenses were between $230 million and $240 million, and Evolus is on track to achieve profitability by the end of 2025.Double-Digit Revenue Growth
Evolus reported a 15.5% revenue growth in the first quarter of 2025, achieving $68.5 million in revenue, supported by a strong commercial engine and market share gains.
Successful Launch of Evolysse
Evolus launched its new product, Evolysse, in April 2025, which has shown strong early momentum and exceeded expectations in terms of clinician interest and early ordering activity.
Increased Customer Engagement
Evolus added 675 new purchasing accounts, reaching a total of more than 16,000 accounts. The company's loyalty program achieved a record with over 220,000 redemptions.
Positive Financial Repositioning
Evolus successfully refinanced its debt facility, reducing borrowing costs by 350 basis points and adding $100 million in incremental available capacity.
International Growth
International revenue contributions increased and are expected to continue outpacing US growth, validating strong growth trajectory outside the US.
---
EOLS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
EOLS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| May 07, 2025 | $11.76 | $10.09 | -14.20% |
| Mar 04, 2025 | $14.35 | $14.17 | -1.25% |
| Nov 06, 2024 | $16.81 | $14.29 | -14.99% |
| Jul 31, 2024 | $12.42 | $14.04 | +13.04% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Evolus Inc (EOLS) report earnings?
Evolus Inc (EOLS) is schdueled to report earning on Jul 30, 2025, TBA Not Confirmed.
What is Evolus Inc (EOLS) earnings time?
Evolus Inc (EOLS) earnings time is at Jul 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EOLS EPS forecast?
EOLS EPS forecast for the fiscal quarter 2025 (Q2) is -0.09.
---